Furthermore, the mechanism by which catalpol alleviates hepatic insulin resistance by regulating the expression of the PI3K/AKT pathway and its downstream glucose metabolism-related proteins has been demonstrated in T2D mice and IR-HepG2 cells models (Yan et al., 2018). This evidence concerns the gene AKT1 and Insulin resistance.